James Shaw is Professor of Regenerative Medicine for Diabetes at Newcastle University and Honorary Physician at the Newcastle Diabetes Centre and Freeman Hospital. He leads the Regenerative Medicine Theme within the Institute of Cellular Medicine, Newcastle University. In addition to setting up a translational research laboratory he has established a regional insulin pump service, is a member of the Newcastle pancreas transplant team and clinical lead for islet transplantation. He is Chief Investigator for a £1.3M Diabetes UK multicentre grant to foster collaborative UK research in severe hypoglycaemia, optimised analogue treatment, pump therapy and continuous glucose monitoring. He chairs the United Kingdom Islet Transplant Consortium who attained dedicated NHS funding for this intervention as an established clinical procedure in 2008. This has underpinned a further multicentre Diabetes UK grant to prospectively evaluate biomedical and psychosocial outcomes in all UK islet recipients. He is clinical lead for the Newcastle Biomanufacturing Cellular Therapies Facility exploring novel stem and adult cell therapies for those with type 1 diabetes with a more recent focus on endogenous beta-cell regeneration.
For more information please click here.